SCHEMBL4332984

SCHEMBL4332984

COc1c(C(=O)NCc2ccoc2)ccc2[nH]nc(-c3cc4ccccc4o3)c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.40
KMT2A Q03164 3/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
MAOB P27338 1/20 0.39
ALDH1A1 P00352 3/20 0.38
MAPT P10636 3/20 0.38
NPSR1 Q6W5P4 2/20 0.38
JAK2 O60674 1/20 0.38
JAK3 P52333 1/20 0.38
HPGD P15428 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
TP53 P04637 2/20 0.37
TDP1 Q9NUW8 2/20 0.36
NPC1 O15118 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
HSD17B10 Q99714 2/20 0.36
MEN1 O00255 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2862654 0.87 SMN1; SMN2 (0.51) KDM4EALDH1A1MAPTNPSR1HPGD
SCHEMBL4343252 0.86 HSD17B10 (0.49) KDM4EKMT2AL3MBTL1ALDH1A1MAPT
SCHEMBL4334635 0.85 EGLN1 (0.39) MAPTSMN1; SMN2KDR
SCHEMBL4341426 0.85 GAA (0.50) KDM4EKMT2AALDH1A1MAPTNPSR1
SCHEMBL4327612 0.84 JAK2 (0.40) KDM4EKMT2AL3MBTL1ALDH1A1MAPT
SCHEMBL4331838 0.84 HPGD (0.53) KDM4EKMT2AL3MBTL1ALDH1A1JAK2
SCHEMBL2866722 0.83 GSK3B (0.41) JAK2JAK3
SCHEMBL4333960 0.83 MAPK10 (0.37) KDM4EALDH1A1JAK2JAK3HPGD
SCHEMBL4334565 0.82 LMNA (0.41) KDM4EKMT2AALDH1A1MAPTNPSR1
SCHEMBL4336829 0.82 KDM4E (0.43) KDM4EKMT2AALDH1A1MAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 KDM4E 2531/4885KMT2A 2212/4885L3MBTL1 2399/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 KDM4E 2531/4885KMT2A 2212/4885L3MBTL1 2399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.